to - 医索

找到约 1557 条结果

Cognitive function in women with HR advanced breast cancer treated withendocrine therapy ± CDK46 inhibitors

医客学院 - 会议报告集

Balancing efficacy and quality of lifein hormone receptor-positivemetastatic breast cancer

医客学院 - 会议报告集

Abstract LBA509Rates of pathologic complete response(pCR)after neoadjuvant datopotomab deruxtecan(Dato-DXd) Results from the l-SPY 2.2trial

医客学院 - 会议报告集

Abemaciclib plus fulvestrant vs fulvestrant alone for HR HER2-advanced breast cancer following progression onprior CDK46 inhibitor plus endocrine therapy Primaryoutcome of the Phase 3 postMONARCH

医客学院 - 会议报告集

Taiwan National Lung Cancer Early Detection Program for HeavySmokers and Non-smokers with Family History of Lung Cancer

医客学院 - 会议报告集

Subcutaneous amivantamab vs intravenous amivantamabboth in combination with lazertinib, in refractoryEGFR-mutated,advanced non-small cell lung cancer

医客学院 - 会议报告集

Smoking history requirement and lungcancer screening eligibility disparities.

医客学院 - 会议报告集

Phase lalb trial of zongertinib (Bl 1810631),aHER2-specific tyrosine kinase inhibitor in patients withHER2 aberration-positive solid tumors updatedPhase la data from Beamion LUNG-1, includingprogression-

医客学院 - 会议报告集

Milestones Early Detection to Nodal Status and Every thing in Between

医客学院 - 会议报告集

ICARUS-LUNG01 A phase 2 Study of Dato-DXd inpatients with previously treated advanced NSCLc, withsequential tissue biopsies and biomarkers analysis topredict treatment outcome

医客学院 - 会议报告集

今日实时热搜